Stay updated with breaking news from Cleerly Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cleerly, Inc., a digital healthcare company focused on AI-driven heart disease diagnosis, has announced continued strong scientific evidence supporting the clinical utility of its products, detailing a study published online in the European Heart Journal Cardiovascular Imaging.
This article outlines the need for a nationwide public-private network of assurance laboratories that would aid in the evaluation and development of artificial
Cleerly, an artificial intelligence (AI) digital healthcare company, has announced it was named “Best Overall AI Solution” in the sixth annual AI Breakthrough Awards program conducted by AI Breakthrough, a leading market intelligence organization that recognizes the top companies, technologies and products in the global Artificial Intelligence (AI) market.
Postmenopausal women with clogged arteries are at higher risk of heart attacks than men of similar age, according to research presented at EACVI 2023, a scientific congress of the European Society of Cardiology (ESC),1 and published in European Heart Journal - Cardiovascular Imaging.2 The study in nearly 25,000 adults used imaging techniques to examine the arteries and followed patients for heart attacks and death. “The study suggests that a given burden of atherosclerosis is riskier in postmenopausal women than it is in men of that age,” said study author Dr. Sophie van Rosendael of Leide...
The Society of Cardiovascular Computed Tomography (SCCT) has released an update on the device manufacturers set to display their latest technologies at the 2022 Annual Scientific Meeting (SCCT2022) being held in Las Vegas July 15 – 17.